DrugPatentWatch Database Preview
RAXIBACUMAB Drug Profile
» See Plans and Pricing
Summary for Tradename: RAXIBACUMAB
Patents: | 10 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Recent Clinical Trials: | See clinical trials for RAXIBACUMAB |
Recent Clinical Trials for RAXIBACUMAB
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 4 |
Human Genome Sciences Inc., a GSK Company | Phase 3 |
GlaxoSmithKline | Phase 3 |
Pharmacology for RAXIBACUMAB
Mechanism of Action | Anthrax Protective Antigen-directed Antibody Interactions |
Patent Text Search: US Patents for RAXIBACUMAB
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Human Genome Sciences Inc. | RAXIBACUMAB | raxibacumab | INJECTABLE; IV (INFUSION) | 125349 | 001 | 2012-12-14 | Start Trial | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
Human Genome Sciences Inc. | RAXIBACUMAB | raxibacumab | INJECTABLE; IV (INFUSION) | 125349 | 001 | 2012-12-14 | Start Trial | University of Kentucky Research Foundation (Lexington, KY) | 2033-03-13 | RX | search | |
Human Genome Sciences Inc. | RAXIBACUMAB | raxibacumab | INJECTABLE; IV (INFUSION) | 125349 | 001 | 2012-12-14 | Start Trial | The Regents of the University of California (Oakland, CA) | 2035-02-24 | RX | search | |
Human Genome Sciences Inc. | RAXIBACUMAB | raxibacumab | INJECTABLE; IV (INFUSION) | 125349 | 001 | 2012-12-14 | Start Trial | LA JOLLA BIOLOGICS, INC. (San Diego, CA) | 2036-04-26 | RX | search | |
Human Genome Sciences Inc. | RAXIBACUMAB | raxibacumab | INJECTABLE; IV (INFUSION) | 125349 | 001 | 2012-12-14 | Start Trial | Aegis Therapeutics LLC (San Diego, CA) | 2026-06-23 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for RAXIBACUMAB
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2013120497 | Start Trial |
Canada | 2862476 | Start Trial |
Canada | 2765727 | Start Trial |
China | 104114705 | Start Trial |
Japan | 2015508646 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |